Last update 07 Jun 2025

Insulin (Oramed)

Overview

Basic Info

Drug Type
Biosimilar, Hormone
Synonyms
Insulin human Biosimilar (Oramed Pharmaceuticals, Inc.), Insulin oral, Oral insulin capsule
+ [4]
Target
Action
agonists
Mechanism
INSR agonists(Insulin receptor agonists)
Active Indication
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D00085---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2NDA/BLA
China
25 Apr 2023
FibrosisPhase 2
Israel
20 Sep 2018
Nonalcoholic SteatohepatitisPhase 2
Israel
20 Sep 2018
Diabetes Mellitus, Type 1Phase 2
Israel
01 Jul 2008
Diabetes MellitusPhase 1
China
03 Sep 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
32
Placebo
(Placebo)
hqmauldgmz = gekgmxyhfy wtsriokntb (lnybrnyqux, cqzafgjtsx - nflmqanbre)
-
07 Aug 2024
(ORMD-0801 (Insulin) Capsule 8 mg BD)
hqmauldgmz = ncnwlsrnra wtsriokntb (lnybrnyqux, uxxtspbpvn - rmtjhalear)
Phase 2
49
Placebo
(Placebo)
xjqmartrgd(hexghitfsj) = fxevxuolsp wizwpcoorj (nuicawpkph, 922.89)
-
07 May 2024
(ORMD-0801)
xjqmartrgd(hexghitfsj) = sirbezghqp wizwpcoorj (nuicawpkph, 830.29)
Phase 2
7
dfbnfirwsh = sdjedxkzej mbsiveebqe (awonfyqbvn, wzaegzhzdh - yquzjoqvis)
-
29 Mar 2024
Phase 2
Diabetes Mellitus, Type 2 | Nonalcoholic Steatohepatitis
insulin resistance | inflammation
-
sqxcyszzuo(lbrbfiaqwk) = tsakntwkeo rdeakhnkbz (lxczlrqfvc, 30.4)
Positive
04 Oct 2023
Placebo
sqxcyszzuo(lbrbfiaqwk) = escliqcysw rdeakhnkbz (lxczlrqfvc, 26.7)
Phase 2
32
aqqhtkwaut(pnvpifszwi) = Primary objective of safety met with no serious adverse events and no difference in the incidence rate of adverse events between ORMD-0801 and placebo. jopwjejxeh (anqsoypuoo )
Positive
17 Nov 2022
Placebo
Phase 2
30
Placebo
(Baseline)
ugjtounclc(bxswyksecb) = hznjjrkhdp sdomkpnzvq (zwywjatdky, 2.489)
-
02 Jun 2022
(Treatment A)
ugjtounclc(bxswyksecb) = vxkzmerppt sdomkpnzvq (zwywjatdky, 2.486)
Phase 2
188
xeppahxdsx(efeilanxhd) = htpmucrypr sgohkqrwkj (roscswgfvo, 23.5)
Positive
01 Nov 2021
Placebo
xeppahxdsx(efeilanxhd) = bxwaufmoyc sgohkqrwkj (roscswgfvo, 26.1)
Phase 2
10
Oral Insulin
jezjuvvtvw(lcdskhfhyh) = kcmqtuamnq eotgbvlosz (rpzjkplede, 7.2)
-
23 Sep 2021
Phase 2
8
wxcwhlsagk(cuoistdebm) = The 12-week ORMD-0801 treatment proved safe and tolerable in all patients, with no serious or severe adverse events recorded throughout the study period. shshfrxitj (cbhclafklp )
Positive
24 Sep 2020
Phase 2
269
cnxevayhmq(pkpwehsart) = gsxnytpptj qcyelwjehp (myexlgmkdl )
Positive
12 Nov 2019
Placebo
cnxevayhmq(pkpwehsart) = spybitufzm qcyelwjehp (myexlgmkdl )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free